U.S. Capital Markets Stock News

In the first quarter of 2026, CoStar Group reported US$897 million in sales versus US$732 million a year earlier, with net income improving to US$3 million from a US$15 million loss, while also confirming full-year 2026 revenue and earnings guidance. At the same time, CoStar is set to be removed from the Nasdaq-100 Index and is pressing ahead with its digital real estate expansion, including Homes.com and broader marketplace growth, even as insiders have recently committed US$6 million to...

Readers hoping to buy MSCI Inc. ( NYSE:MSCI ) for its dividend will need to make their move shortly, as the stock is...

USCB Financial Holdings, Inc. ( NASDAQ:USCB ) stock is about to trade ex-dividend in 3 days. The ex-dividend date is...

There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its quarterly...

It's been a pretty great week for Construction Partners, Inc. ( NASDAQ:ROAD ) shareholders, with its shares surging 12...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

In a recent development in the realm of digital payments, RemitBee Inc., a Canadian fintech platform, has announced a collaboration with Visa Canada to enhance cross-border payment services. By integrating with Visa Direct, RemitBee aims to provide faster and more secure international transfers to over 190 countries, addressing common issues faced by Canada's immigrant community in sending money abroad. This collaboration not only signifies an important milestone for Canada's domestic fintech...

Last week, you might have seen that Mistras Group, Inc. ( NYSE:MG ) released its quarterly result to the market. The...

Some Antero Resources Corporation ( NYSE:AR ) shareholders may be a little concerned to see that the Chief Compliance...

It's been a good week for StandardAero, Inc. ( NYSE:SARO ) shareholders, because the company has just released its...

Some Seagate Technology Holdings plc ( NASDAQ:STX ) shareholders may be a little concerned to see that the Executive VP...

It's been a pretty great week for Nephros, Inc. ( NASDAQ:NEPH ) shareholders, with its shares surging 15% to US$3.52 in...

It looks like Provident Financial Services, Inc. ( NYSE:PFS ) is about to go ex-dividend in the next three days. The...

A week ago, Codexis, Inc. ( NASDAQ:CDXS ) came out with a strong set of quarterly numbers that could potentially lead...

We wouldn't blame Morningstar, Inc. ( NASDAQ:MORN ) shareholders if they were a little worried about the fact that...

Soft earnings didn't appear to concern Landstar System, Inc.'s ( NASDAQ:LSTR ) shareholders over the last week. We did...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Honeywell...

The analysts might have been a bit too bullish on Applied Optoelectronics, Inc. ( NASDAQ:AAOI ), given that the company...

It's shaping up to be a tough period for Turtle Beach Corporation ( NASDAQ:TBCH ), which a week ago released some...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see SB Financial...

It looks like Exxon Mobil Corporation ( NYSE:XOM ) is about to go ex-dividend in the next three days. The ex-dividend...

Investors in Starz Entertainment Corp. ( NASDAQ:STRZ ) had a good week, as its shares rose 2.2% to close at US$19.79...

In the first quarter of 2026, FIGS, Inc. reported net revenue of US$159.9 million, up from US$124.9 million a year earlier, and moved from a small net loss to net income of US$6.29 million, with basic earnings per share of US$0.04. The company’s strong quarter was underpinned by 28% year-over-year net revenue growth, passing three million active customers and prompting management to raise full-year 2026 revenue guidance to 14%–16% growth, even as this implied slower growth than the first...

In early May 2026, Praxis Precision Medicines reported a first-quarter net loss of US$92.56 million, while also securing FDA acceptance of new drug applications for ulixacaltamide in essential tremor and relutrigine in SCN2A and SCN8A developmental and epileptic encephalopathies. Alongside these filings, Praxis highlighted positive early-stage data for elsunersen showing a very large placebo-adjusted seizure reduction in SCN2A-DEE, underscoring growing clinical momentum across its central...